Search Results

Monogram Orthopaedics Inc. today announced it has joined NVIDIA Inception, a program designed to help companies evolve faster through cutting-edge technology and access to the latest technical resources from NVIDIA.

GV20 Therapeutics announced today that it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements.

CellChorus Inc. today announced it has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in artificial intelligence (AI) and data sciences.

BioSig Technologies, Inc. today announced that its subsidiary BioSig AI Sciences, Inc. (BAIS) was selected to join NVIDIA Inception, a program designed to partner with companies revolutionizing industries with advancements in artificial intelligence (AI) and data sciences.

Continuing on its commitment to advance the field of reproductive medicine, Inception Fertility™ (Inception), the largest provider of comprehensive fertility products and services in North America, proudly announces its participation at 2023 ASRM Scientific Congress, taking place October 14-18, 2023, in New Orleans, Louisiana.

Inception Fertility™ (Inception) announces today 36 of abstracts from its clinical network, The Prelude Network® (Prelude), have been accepted by the American Society for Reproductive Medicine (ASRM) to be presented at the 2023 ASRM Scientific Congress, taking place October 14-18, 2023, in New Orleans, Louisiana.

Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences industry and a leader in supply chain solutions for the reproductive medicine markets, announced a multi-year agreement with Inception Fertility™, North America’s largest provider of comprehensive fertility services.

Astellas Pharma’s new life sciences center houses its first U.S.-based SakuLab, an incubator space for external partners, as well as its engineered small molecules unit.